Quick navigation menu :
Oligonucleotides & Peptides
Expertise available from 1center of excellence:
CEPiA offers customized services (manufacturing and analytical) from clinical phase to submission and launch (grams scale up to kilograms quantities), including regulatory support, as well as commercial supplies.
cGMP API manufacturing can be combined with Drug Product and Devices technologies. Our facilities are regularly inspected by Health Authorities, including FDA, EMA and PMDA. One of our current development is the oligonucleotide-peptide conjugation.
Peptide production and development:
Through Sanofi’s 25 years experience in the field of oligonucleotides, CEPiA can provide different classes of Oligonucleotides such as DNA, 2’-O-Modified, phosphorothioate derivatives.